Free Trial

BMO Capital Markets Has Lowered Expectations for DuPont de Nemours (NYSE:DD) Stock Price

DuPont de Nemours logo with Basic Materials background

DuPont de Nemours (NYSE:DD - Get Free Report) had its target price reduced by stock analysts at BMO Capital Markets from $107.00 to $105.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an "outperform" rating on the basic materials company's stock. BMO Capital Markets' price target would suggest a potential upside of 35.49% from the stock's current price.

Several other research firms have also recently issued reports on DD. Royal Bank of Canada raised their price objective on shares of DuPont de Nemours from $102.00 to $104.00 and gave the stock an "outperform" rating in a research report on Thursday, November 7th. Morgan Stanley lifted their price target on shares of DuPont de Nemours from $88.00 to $94.00 and gave the company an "equal weight" rating in a research report on Monday, October 21st. Wells Fargo & Company increased their price objective on DuPont de Nemours from $105.00 to $107.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Barclays increased their price target on DuPont de Nemours from $84.00 to $85.00 and gave the stock an "underweight" rating in a report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of DuPont de Nemours from $104.00 to $101.00 and set an "overweight" rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, DuPont de Nemours has a consensus rating of "Moderate Buy" and a consensus target price of $98.00.

Read Our Latest Stock Analysis on DD

DuPont de Nemours Price Performance

DD traded up $0.84 during trading on Thursday, reaching $77.50. The company's stock had a trading volume of 3,241,385 shares, compared to its average volume of 2,547,447. The company has a quick ratio of 1.49, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The firm has a fifty day simple moving average of $79.66 and a two-hundred day simple moving average of $81.40. The company has a market cap of $32.39 billion, a price-to-earnings ratio of 40.79, a PEG ratio of 1.53 and a beta of 1.35. DuPont de Nemours has a 1 year low of $61.14 and a 1 year high of $90.06.

DuPont de Nemours (NYSE:DD - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The basic materials company reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $1.03 by $0.15. DuPont de Nemours had a return on equity of 6.64% and a net margin of 6.35%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.20 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. The firm's revenue for the quarter was up 4.4% compared to the same quarter last year. As a group, analysts anticipate that DuPont de Nemours will post 3.91 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Jennison Associates LLC boosted its position in DuPont de Nemours by 2.0% in the 3rd quarter. Jennison Associates LLC now owns 491,028 shares of the basic materials company's stock valued at $43,756,000 after buying an additional 9,730 shares during the period. Appian Way Asset Management LP acquired a new stake in shares of DuPont de Nemours in the second quarter valued at $2,978,000. Principal Financial Group Inc. boosted its holdings in DuPont de Nemours by 4.6% in the third quarter. Principal Financial Group Inc. now owns 490,704 shares of the basic materials company's stock valued at $43,727,000 after purchasing an additional 21,435 shares during the period. Oppenheimer & Co. Inc. grew its stake in DuPont de Nemours by 38.4% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 36,082 shares of the basic materials company's stock worth $3,215,000 after purchasing an additional 10,012 shares in the last quarter. Finally, Fiduciary Alliance LLC purchased a new stake in DuPont de Nemours during the 4th quarter worth about $249,000. Institutional investors and hedge funds own 73.96% of the company's stock.

About DuPont de Nemours

(Get Free Report)

DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.

Read More

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Should You Invest $1,000 in DuPont de Nemours Right Now?

Before you consider DuPont de Nemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.

While DuPont de Nemours currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines